Edge Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $214K | Buy |
+316
| New | +$188K | 0.03% | 80 |
|
|
2024
Q4 | – | Sell |
-325
| Closed | -$201K | – | 81 |
|
|
2024
Q3 | $201K | Buy |
+325
| New | +$192K | 0.04% | 75 |
|
|
2022
Q1 | – | Sell |
-49
| Closed | -$33K | – | 416 |
|
|
2021
Q4 | $33K | Hold |
49
| – | – | 0.01% | 210 |
|
|
2021
Q3 | $28K | Buy |
49
+9
| +23% | +$4.94K | 0.01% | 234 |
|
|
2021
Q2 | $20K | Hold |
40
| – | – | ﹤0.01% | 279 |
|
|
2021
Q1 | $18K | Buy |
40
+10
| +33% | +$4.77K | ﹤0.01% | 278 |
|
|
2020
Q4 | $14K | Hold |
30
| – | – | ﹤0.01% | 267 |
|
|
2020
Q3 | $13K | Sell |
30
-7
| -19% | -$2.89K | ﹤0.01% | 304 |
|
|
2020
Q2 | $13K | Hold |
37
| – | – | ﹤0.01% | 434 |
|
|
2020
Q1 | $10K | Hold |
37
| – | – | ﹤0.01% | 402 |
|
|
2019
Q4 | $12K | Buy |
37
+30
| +429% | +$9.1K | ﹤0.01% | 409 |
|
|
2019
Q3 | $2K | Hold |
7
| – | – | ﹤0.01% | 532 |
|
|
2019
Q2 | $2K | Hold |
7
| – | – | ﹤0.01% | 540 |
|
|
2019
Q1 | $2K | Sell |
7
-729
| -99% | -$181K | ﹤0.01% | 523 |
|
|
2018
Q4 | $165K | Hold |
736
| – | – | 0.05% | 150 |
|
|
2018
Q3 | $180K | Hold |
736
| – | – | 0.04% | 152 |
|
|
2018
Q2 | $152K | Buy |
736
+727
| +8,078% | +$154K | 0.04% | 163 |
|
|
2018
Q1 | $2K | Hold |
9
| – | – | ﹤0.01% | 514 |
|
|
2017
Q4 | $1K | Hold |
9
| – | – | ﹤0.01% | 514 |
|
|
2017
Q3 | $2K | Hold |
9
| – | – | ﹤0.01% | 493 |
|
|
2017
Q2 | $2K | Hold |
9
| – | – | ﹤0.01% | 485 |
|
|
2017
Q1 | $1K | Hold |
9
| – | – | ﹤0.01% | 487 |
|
|
2016
Q4 | $1K | Hold |
9
| – | – | ﹤0.01% | 462 |
|
|
2016
Q3 | $1K | Hold |
9
| – | – | ﹤0.01% | 461 |
|
|
2016
Q2 | $1K | Hold |
9
| – | – | ﹤0.01% | 443 |
|
|
2016
Q1 | $1K | Hold |
9
| – | – | ﹤0.01% | 424 |
|
|
2015
Q4 | $1K | Hold |
9
| – | – | ﹤0.01% | 438 |
|
|
2015
Q3 | $1K | Hold |
9
| – | – | ﹤0.01% | 440 |
|
|
2015
Q2 | $1K | Hold |
9
| – | – | ﹤0.01% | 413 |
|
|
2015
Q1 | $1K | Sell |
9
-700
| -99% | -$90.2K | ﹤0.01% | 423 |
|
|
2014
Q4 | $89K | Hold |
709
| – | – | 0.03% | 150 |
|
|
2014
Q3 | $87K | Hold |
709
| – | – | 0.03% | 144 |
|
|
2014
Q2 | $84K | Hold |
709
| – | – | 0.03% | 145 |
|
|
2014
Q1 | $85K | Hold |
709
| – | – | 0.04% | 139 |
|
|
2013
Q4 | $79K | Buy |
709
+9
| +1% | +$895 | 0.04% | 137 |
|
|
2013
Q3 | $65K | Sell |
700
-9
| -1% | -$814 | 0.04% | 126 |
|
|
2013
Q2 | $60K | Buy |
+709
| New | +$59K | 0.04% | 118 |
|
Other funds holding TMO
Edge Wealth Management's TMO Position: Q3 2026 in Review
Edge Wealth Management opened a new position in Thermo Fisher Scientific (TMO) in Q3 2026: 316 shares worth $214K. The stake represents 0.03% of the portfolio and ranks #80 among its holdings. This is a return to the name: Edge Wealth Management previously reported a position in TMO as recently as Q3 2024.
Edge Wealth Management first reported a position in TMO in Q2 2013 and has held it in 37 quarters since. 1,885 funds tracked by Wall St. Rank hold TMO as of Q3 2026.
- Edge Wealth Management held 316 shares of Thermo Fisher Scientific worth $214K as of Q3 2026.
- Thermo Fisher Scientific was a new Edge Wealth Management position in Q3 2026.
- Thermo Fisher Scientific made up 0.03% of Edge Wealth Management's portfolio in Q3 2026, its #80 holding.
- Edge Wealth Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 37 quarters since.
- 1,885 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.
Based on Edge Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.